Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,207
Closed -$134K 694
2021
Q3
$134K Buy
+10,207
New +$138K ﹤0.01% 645
2016
Q3
Sell
-10,030
Closed -$338K 394
2016
Q2
$338K Sell
10,030
-12,529
-56% -$402K 0.03% 313
2016
Q1
$702K Sell
22,559
-47,594
-68% -$1.45M 0.08% 210
2015
Q4
$2.35M Sell
70,153
-8,533
-11% -$317K 0.25% 114
2015
Q3
$2.96M Buy
78,686
+2,746
+4% +$112K 0.28% 87
2015
Q2
$3.67M Sell
75,940
-12,789
-14% -$657K 0.33% 82
2015
Q1
$4.44M Buy
88,729
+20,853
+31% +$1.13M 0.39% 72
2014
Q4
$4.45M Buy
67,876
+2,318
+4% +$161K 0.38% 69
2014
Q3
$4.99M Buy
65,558
+745
+1% +$61.6K 0.47% 56
2014
Q2
$5.34M Sell
64,813
-4,453
-6% -$332K 0.5% 52
2014
Q1
$4.86M Buy
69,266
+8,090
+13% +$555K 0.47% 56
2013
Q4
$4.39M Sell
61,176
-37
-0.1% -$2.69K 0.42% 66
2013
Q3
$4.31M Buy
61,213
+412
+0.7% +$27.6K 0.47% 55
2013
Q2
$3.78M Buy
+60,801
New +$3.75M 0.45% 60

Other funds holding NOV

RegentAtlantic Capital's NOV Position: Q4 2021 in Review

RegentAtlantic Capital sold out of NOV (NOV) in Q4 2021, closing a stake of 10,207 shares — an estimated $134K sold.

RegentAtlantic Capital first reported a position in NOV in Q2 2013 and held it in 14 quarters. The position peaked at $5.34M in Q2 2014. 360 funds tracked by Wall St. Rank hold NOV as of Q4 2021.

  • RegentAtlantic Capital reported no remaining NOV position as of Q4 2021 after selling out during the quarter.
  • RegentAtlantic Capital sold 10,207 NOV shares in Q4 2021, an estimated $134K.
  • RegentAtlantic Capital first reported a position in NOV in Q2 2013 and held it in 14 quarters.
  • RegentAtlantic Capital's NOV position peaked at $5.34M in Q2 2014.
  • 360 funds tracked by Wall St. Rank held NOV as of Q4 2021.

Based on RegentAtlantic Capital's 13F filing for Q4 2021, filed 27 Jan 2022.